Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Spiera

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Geriatrics|January 26, 2005
Inflammatory disease in older adults. Cranial arteritisRobert Spiera, Harry Spiera
Geriatrics|December 24, 2004
Inflammatory diseases in older adults: polymyalgia rheumaticaRobert Spiera, Harry Spiera
The Journal of Rheumatology|October 6, 2005
Autoimmune disease is a risk factor for the development of non-Hodgkin's lymphomaJanet Cuttner, Harry Spiera, Kevin Troy, et al.
The Journal of Investigative Dermatology|March 5, 2002
Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblastsTracy L McGaha, Robert G Phelps, Harry Spiera, et al.
Archives of Internal Medicine|October 24, 2002
Ticlopidine-induced lupus: a report of 4 casesRobert F Spiera, Rosanne S Berman, Andrew J Werner, et al.
Autoimmunity|December 17, 2002
Effect of halofuginone on the development of tight skin (TSK) syndromeTracy McGaha, Takao Kodera, Robert Phelps, et al.
Arthritis and Rheumatism|October 18, 2002
Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanismTracy L McGaha, Takao Kodera, Harry Spiera, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Geriatrics|January 26, 2005
Inflammatory disease in older adults. Cranial arteritisRobert Spiera, Harry Spiera
Geriatrics|December 24, 2004
Inflammatory diseases in older adults: polymyalgia rheumaticaRobert Spiera, Harry Spiera
The Journal of Rheumatology|October 6, 2005
Autoimmune disease is a risk factor for the development of non-Hodgkin's lymphomaJanet Cuttner, Harry Spiera, Kevin Troy, et al.
The Journal of Investigative Dermatology|March 5, 2002
Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblastsTracy L McGaha, Robert G Phelps, Harry Spiera, et al.
Archives of Internal Medicine|October 24, 2002
Ticlopidine-induced lupus: a report of 4 casesRobert F Spiera, Rosanne S Berman, Andrew J Werner, et al.
Autoimmunity|December 17, 2002
Effect of halofuginone on the development of tight skin (TSK) syndromeTracy McGaha, Takao Kodera, Robert Phelps, et al.
Arthritis and Rheumatism|October 18, 2002
Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanismTracy L McGaha, Takao Kodera, Harry Spiera, et al.
Pageof 1